Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022

Rhea-AI Summary

Xencor, Inc. (NASDAQ: XNCR) will announce its second quarter 2022 financial results post-market on August 3, 2022. A conference call and webcast will take place at 4:30 p.m. ET to discuss these results alongside a corporate update. The webcast will be accessible on the company's investor website and available for archiving for 30 days.

Xencor specializes in developing engineered antibodies and cytokines aimed at treating cancer and autoimmune disorders, with over 20 candidates in clinical development using its advanced XmAb® technology.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022.

Xencor management will host a webcast and conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results and provide a corporate update.

The live webcast will be available under "Events & Presentations" in the Investors section of the Company's website located at investors.xencor.com and will be archived for at least 30 days. Participants may register for the conference call at the following link: register.vevent.com/register/BI8b3886bf9772414c8dd5900d3aa4457b.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb^® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005918/en/

Charles Liles

cliles@xencor.com

Source: Xencor, Inc.

FAQ

When will Xencor release its Q2 2022 financial results?

Xencor will release its Q2 2022 financial results after the market closes on August 3, 2022.

What time is Xencor's Q2 2022 earnings call?

The earnings call for Q2 2022 will be held at 4:30 p.m. ET on August 3, 2022.

How can I access Xencor's financial results webcast?

The webcast for Xencor's financial results can be accessed on the Investors section of their website.

What type of technologies is Xencor developing?

Xencor is developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases.